Insulin resistance following continuous, chronic olanzapine treatment: An animal model
- 30 September 2008
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 104 (1-3) , 23-30
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Body mass index, waist circumference and quality of life in individuals with schizophrenia☆Schizophrenia Research, 2007
- Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic EffectsNeuropsychopharmacology, 2006
- Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidolThe British Journal of Psychiatry, 2005
- Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female ratsBehavioural Brain Research, 2005
- Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and managementDiabetes & Vascular Disease Research, 2005
- Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitroEuropean Neuropsychopharmacology, 2004
- Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo OccupancyThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Glucose uptake and insulin action in human adipose tissue—influence of BMI, anatomical depot and body fat distributionInternational Journal of Obesity, 2002
- Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic StudyAmerican Journal of Psychiatry, 2000
- Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 1996